Jump to content

Amphastar Pharmaceuticals

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Melcous (talk | contribs) at 11:31, 10 January 2016 (fix spelling publically --> publicly). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Amphastar Pharmaceuticals is a publicly traded American pharmaceutical company.[1] Its products include Enoxaparin Sodium Injection, Cortrosyn, Amphadase, Emergency Syringes in Luer-Jet, Lidocaine, Naloxone, and Phytonadione Injection.[2][3]

Controversies

Amphastar has been criticized for its pricing of naloxone, a drug that treats opiod overdose.[4]

References

  1. ^ "Amphastar Pharmaceuticals, Inc. (AMPH)". NASDAQ.com. NASDAQ OMX Group. Retrieved 3 January 2016.
  2. ^ Dions, Don. "Amphastar Pharmaceuticals IPO Could Be A Star Among Biotech Stocks". Seeking Alpha. Retrieved 3 January 2016. {{cite web}}: Cite has empty unknown parameter: |1= (help)
  3. ^ "Products". amphastar.com. Retrieved 3 January 2016.
  4. ^ Collins, Sam. "Pharmaceutical Company With Monopoly On Lifesaving Treatment Jacks Up Prices". ThinkProgress.


Stub icon

This United States corporation or company article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Amphastar_Pharmaceuticals&oldid=699123734"